Published in Case Reports Immunol on May 28, 2012
A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. N Engl J Med (2003) 6.57
Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum (2002) 5.12
Prospective study of the incidence and risk factors of postsplenectomy thrombosis of the portal, mesenteric, and splenic veins. Arch Surg (2006) 2.25
Hypercoagulability, renal vein thrombosis, and other thrombotic complications of nephrotic syndrome. Kidney Int (1985) 1.38
Abdominal thrombotic and ischemic manifestations of the antiphospholipid antibody syndrome: CT findings in 42 patients. Radiology (2001) 1.27
The abdominal manifestations of the antiphospholipid syndrome. Rheumatology (Oxford) (2007) 1.23
Thrombosis and hemostasis in renal disease. Kidney Int (1994) 1.09
Laboratory diagnosis and management challenges in the antiphospholipid syndrome. Lupus (2006) 0.95
Multiorgan failure and antiphospholipid antibodies: the catastrophic antiphospholipid (Asherson's) syndrome. Immunobiology (2005) 0.94
Indications for plasma exchange in systemic lupus erythematosus in 2005. Lupus (2005) 0.85